Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01414010 · ClinicalTrials.gov registry record · NA
Effects of Pre-, Pro- & Anti-biotics on Gut Microbiota
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT01414010 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 32 participants.
The verdict
NCT01414010, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to compare and contrast the effects of a prebiotic (Trametes Versicolor), a probiotic (Saccharomyces boulardii) and an antibiotic (amoxicillin) on the gut microbiota of healthy volunteers. It is expected that treatment will result in the rapid and reproducible alterations in fecal microbiota that will spontaneously reverse in the weeks after treatment is discontinued.
Interventions
- DRUG Amoxicillin
- DIETARY_SUPPLEMENT Saccharomyces boulardii
- DIETARY_SUPPLEMENT Trametes versicolor extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2011-08 |
| Est. Completion | 2012-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01414010
The ClinicalTrials.gov registry entry for NCT01414010 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Amoxicillin is the first listed.
NCT01414010 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01414010 about?
NCT01414010 is a clinical study titled "Effects of Pre-, Pro- & Anti-biotics on Gut Microbiota". The purpose of this study is to compare and contrast the effects of a prebiotic (Trametes Versicolor), a probiotic (Saccharomyces boulardii) and an antibiotic (amoxicillin) on the gut microbiota of healthy volunteers. It is expected that treatment will result in the rapid and reproducible alteration...
What is the current status of trial NCT01414010?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2011-08. Estimated completion is 2012-02.
What interventions are being tested in trial NCT01414010?
The interventions under investigation include: Amoxicillin (DRUG), Saccharomyces boulardii (DIETARY_SUPPLEMENT), Trametes versicolor extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01414010?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.